Scaling Science and Sustainability: Voima Ventures Finalises Fund III, north from €100M
Voima Ventures has announced the final closing of its €100M+ Fund III, an Article 8 compliant deep tech fund. Based in both Helsinki and Stockholm, the fund has already begun deploying capital with 8 finalised investments from its first closing to accelerate breakthrough innovations across the Nordic and Baltic deeptech landscape.
Scaling Nordic Deeptech- From Labs to Unicorn Potential
With this closing, Voima Ventures emphasised its unique insight to invest in visionary scientific founders and entrepreneurs who are reshaping whole industries, including Life Sciences, energy, food, quantum and advanced AI, to mention a few.
The new Fund is uniquely positioned to support the next generation of science-driven unicorns. Initial investment tickets range from €200k to €3M, with the capacity for significant follow-on investments.
The firm aims to further grow its presence in the Nordic and Baltic regions while being the go-to and longterm partner for early-stage university spinouts and startups. Since its foundation in 2019, Voima Ventures established itself as a trusted partner for early-stage founders, leveraging deep expertise and networks within academia and industry to bridge the gap between research and commercial success. With over 70% of its portfolio companies originating directly from university spin-offs or research ecosystems, the firm remains committed to fostering groundbreaking innovation at its roots.
Growth and Impact
Voima Ventures prioritises high-potential VC investments that deliver both financial returns and positive environmental and societal impact. The fund is committed to ESG principles and is aligned with the EU’s Sustainable Finance Disclosure Regulation (SFDR), as an Article 8 fund.
”In deeptech, pushing the boundaries of science-driven entrepreneurship isn’t just about innovation, it’s about delivering meaningful global impact alongside strong returns,” said Inka Mero, Founder and Managing Partner of Voima Ventures.
”Our recent Impact Report highlights this commitment, showing that Voima Ventures Fund III achieves a net impact score of +48%, compared to the average -8% impact of US Fortune 500 companies. This means that every Euro we invest creates significant positive change, driven by more sustainable practices and transformative technologies.”
The Journey Continues
Lately, Voima Ventures has focused on expanding its presence in Sweden, hiring Stina Wallmark as Life Sciences Investment Director and promoting Jenny Engerfelt to Partner earlier in the year. Together, they are driving efforts to strengthen operations and manage the growing deal flow from the region.
The fund will make 25-30 investments and has so far done 8 new investments. Closed investments include examples like ÄIO – replaces palm oil, coconut oil and animal fats with sustainable and healthier alternatives, Liquid sun – sustainable aviation fuel from carbon dioxide and Avenue Biosciences – protein optimization platform enhancing production yield and the quality of pharmaceuticals.
”The Nordic and Baltic regions are setting the global standard for deep tech innovation, and we are proud to grow alongside this thriving ecosystem,” said Jussi Sainiemi, Partner at Voima Ventures.
”With a unique blend of cutting-edge research and entrepreneurial talent, these regions are driving solutions that not only tackle global challenges but also redefine industries, creating sustainable value for future generations.”
Additional information:
Inka Mero, Founder and Managing Partner
+358 45 121 4394
***
Voima Ventures
Voima Ventures, founded in 2019, is a Nordic early-stage investor investing in science-based innovations and companies across the Nordics and Baltics. Voima Ventures help founders to accelerate the growth of deep technology ventures to global markets. Voima Ventures is a team of 12 investment and growth entrepreneurship professionals who share a passion for science-based tech. Voima Ventures holds a strong track record in investing in high-growth science-based solutions by being an early investor in success stories like Solar Foods, Dispelix, MVision, Betolar and EniferBio.